GoodRx Statistics
Share Statistics
GoodRx has 381.14M shares outstanding. The number of shares has increased by -3.51% in one year.
| Shares Outstanding | 381.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.45% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 316.86M |
| Failed to Deliver (FTD) Shares | 100 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 7.93M, so 2.08% of the outstanding shares have been sold short.
| Short Interest | 7.93M |
| Short % of Shares Out | 2.08% |
| Short % of Float | 2.5% |
| Short Ratio (days to cover) | 5.48 |
Valuation Ratios
The PE ratio is -310 and the forward PE ratio is 11.46.
| PE Ratio | -310 |
| Forward PE | 11.46 |
| PS Ratio | 3.66 |
| Forward PS | 1.8 |
| PB Ratio | 3.61 |
| P/FCF Ratio | 33.31 |
| PEG Ratio | n/a |
Enterprise Valuation
GoodRx Inc. has an Enterprise Value (EV) of 2.79B.
| EV / Earnings | -314.38 |
| EV / Sales | 3.72 |
| EV / EBITDA | 25.62 |
| EV / EBIT | -103.23 |
| EV / FCF | 33.78 |
Financial Position
The company has a current ratio of 7.12, with a Debt / Equity ratio of 0.86.
| Current Ratio | 7.12 |
| Quick Ratio | 7.12 |
| Debt / Equity | 0.86 |
| Total Debt / Capitalization | 46.28 |
| Cash Flow / Debt | 0.21 |
| Interest Coverage | -0.48 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -0.29%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | -0.01% |
| Return on Capital (ROIC) | -0.29% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | -12.78K |
| Employee Count | 694 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -46.70M |
| Effective Tax Rate | 0.84 |
Stock Price Statistics
The stock price has increased by -34.44% in the last 52 weeks. The beta is 1.39, so GoodRx 's price volatility has been higher than the market average.
| Beta | 1.39 |
| 52-Week Price Change | -34.44% |
| 50-Day Moving Average | 4.76 |
| 200-Day Moving Average | 6.82 |
| Relative Strength Index (RSI) | 36.78 |
| Average Volume (20 Days) | 1.43M |
Income Statement
In the last 12 months, GoodRx had revenue of 750.26M and earned -8.87M in profits. Earnings per share was -0.02.
| Revenue | 750.26M |
| Gross Profit | 683.34M |
| Operating Income | -27.01M |
| Net Income | -8.87M |
| EBITDA | 108.82M |
| EBIT | -27.01M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 672.30M in cash and 711.07M in debt, giving a net cash position of -38.77M.
| Cash & Cash Equivalents | 672.30M |
| Total Debt | 711.07M |
| Net Cash | -38.77M |
| Retained Earnings | -1.46B |
| Total Assets | 1.35B |
| Working Capital | 512.44M |
Cash Flow
In the last 12 months, operating cash flow was 138.29M and capital expenditures -55.77M, giving a free cash flow of 82.53M.
| Operating Cash Flow | 138.29M |
| Capital Expenditures | -55.77M |
| Free Cash Flow | 82.53M |
| FCF Per Share | 0.2 |
Margins
Gross margin is 91.08%, with operating and profit margins of -3.6% and -1.18%.
| Gross Margin | 91.08% |
| Operating Margin | -3.6% |
| Pretax Margin | -7.41% |
| Profit Margin | -1.18% |
| EBITDA Margin | 14.5% |
| EBIT Margin | -3.6% |
| FCF Margin | 11% |
Dividends & Yields
GDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.48% |
| FCF Yield | 5.24% |
Analyst Forecast
The average price target for GDRX is $8, which is 93.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 93.7% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Scores
| Altman Z-Score | 1.27 |
| Piotroski F-Score | 6 |